Systemic sclerosis & Raynaud's

The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study

Rheumatology (Oxford)Published Retrospective cohort study

Main finding · MACEResult — go to the resultAdjusted hazard ratio 1.04 95% CI 0.77–1.42

Authors' conclusion

The risk of MACEs was not significantly increased in Taiwanese patients with SSc, and our investigation effectively identified the factors independently associated with MACEs in SSc patients.

Study context

Population
Patients with systemic sclerosis (SSc) and matched non-SSc individuals, Taiwan's National Health Insurance Research DatabasePropensity score matching (PSM) 1:2
Participants
1,379 vs 2,758
Exposure
SSc vs matched non-SSc individuals
  • SScn = 1,379
  • Non-SScn = 2,758reference
Outcome
MACE
Methodological detailsnationwide, population-based, propensity score matched (1:2), multivariable Cox regression with time-dependent covariates
  • Nationwide
  • Population-based
  • Propensity score matched (1:2)
  • Multivariable Cox regression with time-dependent covariates

Main finding

As reported in the abstract

Adjusted hazard ratio

1.04

95% CI 0.77–1.42

SScvs Non-SSc
aHR 1.04 (95% CI 0.77–1.42)

Observational data: associations, not effects.

Further findings

OutcomeIRR (95% CI)
MI1.76 (1.08–2.86)
Peripheral arterial occlusion disease3.67 (2.84–4.74)
Ischaemic stroke0.89 (0.61–1.29)

Factors independently associated with MACE in SSc

Age, aHR
1.02
Male gender, aHR
2.01
Living in a suburban area, aHR
2.09
Living in a rural area, aHR
3.00
Valvular heart disease, aHR
4.26
RA, aHR
2.14
Use of clopidogrel, aHR
26.65
Use of aspirin, aHR
5.31

Original publication

The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study. Rheumatology (Oxford). Published 11 September 2023. doi:10.1093/rheumatology/kead464

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.